Laverock Therapeutics
Developer of gene control technology to support the development of disease-responsive advanced therapies.
B2X
0
COO
Country
CTO
Email Address
contact@laverocktx.com
Founded Date
January 1, 2022
Headquarters
Latest Funding Round Date
June 30, 2025
Latest Funding Round Amount (USD)
27,500,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
43,500,000
Official Website
Find more companies like Laverock Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.